WOODSTOCK CORP - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOODSTOCK CORP ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2020$103,000
-78.5%
57,2130.0%0.02%
-79.3%
Q2 2020$480,000
+60.0%
57,2130.0%0.08%
+34.4%
Q1 2020$300,000
-3.8%
57,2130.0%0.06%
+19.6%
Q4 2019$312,000
+11.8%
57,2130.0%0.05%
+4.1%
Q3 2019$279,000
-29.5%
57,2130.0%0.05%
-29.0%
Q2 2019$396,000
-0.5%
57,2130.0%0.07%
-2.8%
Q1 2019$398,000
-27.0%
57,213
-38.7%
0.07%
-34.9%
Q4 2018$545,000
-22.6%
93,2640.0%0.11%
-8.4%
Q3 2018$704,000
+93.4%
93,264
+29.5%
0.12%
+77.6%
Q2 2018$364,000
-17.1%
72,0010.0%0.07%
-19.3%
Q1 2018$439,000
-14.1%
72,0010.0%0.08%
-11.7%
Q4 2017$511,000
-0.8%
72,0010.0%0.09%
-4.1%
Q3 2017$515,000
+47.1%
72,001
+29.8%
0.10%
+42.0%
Q2 2017$350,000
-23.6%
55,4890.0%0.07%
-25.0%
Q1 2017$458,000
-2.3%
55,4890.0%0.09%
-3.2%
Q4 2016$469,000
+73.1%
55,489
+39.0%
0.10%
+72.7%
Q3 2016$271,00039,9310.06%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders